I have presented my research on psychedelic-assisted therapy internationally. See below for selected talks.

Please reach out via the contact page to inquire about my availability for speaking engagements.

Dr. Gabby Agin-Liebes presents qualitative data from the NYU Psilocybin Alcohol Use Disorder Study with Dr. Michael Bogenschutz at the Horizons Conference 2022 in New York City.

Dr. Gabby Agin-Liebes presents her research on the long-term follow-up results of the NYU study on psilocybin-assisted therapy for end-of-life distress at the 2020 Psilocybin Summit with colleagues Drs. Alan Davis and Gianni Glick:

Dr. Gabby Agin-Liebes presents qualitative data from the NYU Psilocybin Cancer Study with Dr. Steve Ross at Psychedelic Science 2017. This conference was a a six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical cannabis:

Dr. Gabby Agin-Liebes presents qualitative narratives at the Horizons: Perspectives on Psychedelics Conference in 2015. Horizons is an annual forum that examines the role of psychedelic drugs in science, medicine, culture and spirituality:

Dr. Gabby Agin-Liebes chats with Joe and Kyle on their podcast “Psychedelics Today” about the NYU Psilocybin Cancer Study as well as tips for how to professionally enter the psychedelic field: